GLUE
NASDAQ · Biotechnology
Monte Rosa Therapeutics Inc
$10.57
+0.00 (+0.00%)
Analyst Consensus
Strong Buy
15
Analysts
High
Coverage
Price Target
Analyst Price Target
+263.8% upside
Low Target
$28.40
Average Target
$38.45
High Target
$50.36
Current Price
$10.57
Current
$10.57
$10.57
Target
$38.45
$38.45
$28.40
$38.45 avg
$50.36
Scenario Analysis
Bear Case
$28.40
168.7%
Low target
Base Case
$38.45
+263.8%
Avg target
Bull Case
$50.36
+376.4%
High target
Risk/Reward
2.2x
Favorable
Price in Context
52-Week High
$25.77
-59.0% from high
52-Week Low
$9.68
+9.2% from low
Target vs 52W High
$38.45
+49.2% vs high
Peer Consensus — Biotechnology
| Stock | Consensus | Analysts | Buy % | Target | Upside |
|---|---|---|---|---|---|
| ABBV | Strong Buy | 38 | 82% | $257.58 | -12.2% |
| AMGN | Hold | 42 | 43% | $190.87 | -58.8% |
| GILD | Strong Buy | 36 | 83% | $362.68 | +114.3% |
| VRTX | Strong Buy | 39 | 82% | $438.34 | -20.2% |
| MRNA | Hold | 31 | 32% | $149.45 | -46.0% |
| REGN | Buy | 36 | 72% | $76.80 | -91.7% |
| NTRA | Strong Buy | 31 | 90% | $142.91 | -55.0% |
| RVMD | Strong Buy | 31 | 94% | $114.11 | -42.6% |